FT Weekend: A new weight-loss drug works. Is ...

UK Prime Minister Andy Burnham returns to the Labour conference to sell his vision, EU countries are considering a Nato-style joint response to Russia’s hybrid war, and foreign investors have been buying up Panama’s debt despite social unrest and threats from US President Donald ...  Show more

Xi Jinping said the US and China should avoid being drawn into a “conflict” in remarks at the White House, and Brussels has warned Britain needs to raise tariffs on Chinese cars if it wants to avoid barriers that would hit crucial exports. Plus, dozens of foreign officials walked ...  Show more

A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ...  Show more

What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ...  Show more

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more

Ozempic has fast become the buzzword for dramatic weight loss, and considering the results users have been reporting, it’s easy to see why. To discuss the supposed miracle drug, Piers Morgan has assembled an all-star panel of doctors and patients, including; Journalist and author ...  Show more